MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marill, J.
Right arrow Articles by Chabot, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marill, J.
Right arrow Articles by Chabot, G. G.

Vol. 58, Issue 6, 1341-1348, December 2000

Identification of Human Cytochrome P450s Involved in the Formation of All-trans-Retinoic Acid Principal Metabolites

Julie Marill, Thierry Cresteil, Michel Lanotte, and Guy G. Chabot

Institut National de la Santé et de la Recherche Médicale, Institut Universitaire d'Hématologie (Université Paris 7), Hôpital Saint-Louis, Paris, France (J.M., M.L., G.G.C.); and Institut Gustave-Roussy, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Villejuif, France (T.C.)

Cytochrome P450 (P450)-dependent metabolism of all-trans-retinoic acid (atRA) is important for the expression of its biological activity. Because the human P450s involved in the formation of the principal atRA metabolites have been only partially identified, the purpose of this study was to identify the human P450s involved in atRA metabolism. The use of phenotyped human liver microsomes (n = 16) allowed the identification of the following P450s: 2B6, 2C8, 3A4/5, and 2A6 were involved in the formation of 4-OH-RA and 4-oxo-RA; 2B6, 2C8, and 2A6 correlated with the formation of 18-OH-RA; and 2A6, 2B6, and 3A4/5 activities correlated with 5,6-epoxy-RA formation (30-min incubation, 10 µM atRA, HPLC separation, UV detection 340 nm). The use of 15 cDNA-expressed human P450s from lymphoblast microsomes, showed the formation of 4-OH-RA by CYP3A7 > CYP3A5 > CYP2C18 > CYP2C8 > CYP3A4 > CYP2C9, whereas the 18-OH-RA formation involved CYPs 4A11 > 3A7 > 1A1 > 2C9 > 2C8 > 3A5 > 3A4 >2C18. Kinetic studies identified 3A7 as the most active P450 in the formation of three of the metabolites: for 4-OH-retinoic acid, 3A7 showed a Vmax/Km of 127.7, followed by 3A5 (Vmax/Km = 25.6), 2C8 (Vmax/Km = 24.5), 2C18 (Vmax/Km = 15.8), 3A4 (Vmax/Km = 5.7), 1A1 (Vmax/Km = 5.0), and 4A11 (Vmax/Km = 1.9); for 4-oxo-RA, 3A7 showed a Vmax/Km of 13.4, followed by a 10-fold lower activity for both 2C18 and 4A11 (Vmax/Km = 1.2); and for 18-OH-RA, 3A7 showed a Vmax/Km of 10.5 compared with a Vmax/Km of 2.1 for 4A11 and 2.0 for 2C8. 5,6-Epoxy-RA was only detected at high substrate concentrations in this system (>10 µM), and P450s 2C8, 2C9, and 1A1 were the most active in its formation. The use of embryonic kidney cells (293) stably transfected with human P450 cDNA confirmed the major involvement of P450s 3A7, 1A1, and 2C8 in the oxidation of atRA, and to a lesser extent, 1A2, 2C9, and 3A4. In conclusion, several human P450s involved in atRA metabolism have been identified, the expression of which was shown to direct atRA metabolism toward the formation of specific metabolites. The role of these human P450s in the biological and anticancer effects of atRA remains to be elucidated.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. A. Schoch, J. K. Yano, M. R. Wester, K. J. Griffin, C. D. Stout, and E. F. Johnson
Structure of Human Microsomal Cytochrome P450 2C8: EVIDENCE FOR A PERIPHERAL FATTY ACID BINDING SITE
J. Biol. Chem., March 5, 2004; 279(10): 9497 - 9503.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Liu, R. M. Russell, and X.-D. Wang
Exposing Ferrets to Cigarette Smoke and a Pharmacological Dose of {beta}-Carotene Supplementation Enhance In Vitro Retinoic Acid Catabolism in Lungs via Induction of Cytochrome P450 Enzymes
J. Nutr., January 1, 2003; 133(1): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Burk, H. Tegude, I. Koch, E. Hustert, R. Wolbold, H. Glaeser, K. Klein, M. F. Fromm, A. K. Nuessler, P. Neuhaus, et al.
Molecular Mechanisms of Polymorphic CYP3A7 Expression in Adult Human Liver and Intestine
J. Biol. Chem., June 28, 2002; 277(27): 24280 - 24288.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Kelkenberg, A. H. Wagner, J. Sarhaddar, M. Hecker, and H. E. von der Leyen
CCAAT/Enhancer-Binding Protein Decoy Oligodeoxynucleotide Inhibition of Macrophage-Rich Vascular Lesion Formation in Hypercholesterolemic Rabbits
Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 949 - 954.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Idres, G. Benoît, M. A. Flexor, M. Lanotte, and G. G. Chabot
Granulocytic Differentiation of Human NB4 Promyelocytic Leukemia Cells Induced by All-trans Retinoic Acid Metabolites
Cancer Res., January 1, 2001; 61(2): 700 - 705.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics